Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Microbot Medical ( (MBOT) ) has provided an announcement.
At the Annual Meeting held on December 17, 2024, Microbot Medical’s stockholders voted on three proposals. The first proposal involved electing two nominees to the Board of Directors, with Prattipati Laxminarain and David J. Wilson being elected to serve until the 2027 Annual Meeting. The second proposal approved an amendment to increase the authorized shares of common stock by 600,000, while the third proposal ratified Brightman Almagor Zohar & Co. as the independent registered public accounting firm for 2024.
More about Microbot Medical
YTD Price Performance: -40.73%
Average Trading Volume: 179,553
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $16.47M
For an in-depth examination of MBOT stock, go to TipRanks’ Stock Analysis page.